RecruitingPhase 1NCT06653400

Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy

Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy: a Randomized Controlled Trial

Sponsor

Icahn School of Medicine at Mount Sinai

Enrollment

60 participants

Start Date

Feb 27, 2025

Study Type

INTERVENTIONAL

Conditions

Analgesia Abnormal Uterine Bleeding Paracervical Block

Summary

A randomized double-blind placebo controlled trial comparing the effect of a combined ketorolac and lidocaine paracervical block with a standard lidocaine paracervical block on procedure related pain with office hysteroscopies.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Lidocaine, a drug called ketorolac, and others for people with abnormal uterine bleeding, analgesia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.